Ocrelizumab during pregnancy and lactation: Rationale and design of the MINORE and SOPRANINO studies in women with MS and their infants

  1. Bove, R.
  2. Hellwig, K.
  3. Pasquarelli, N.
  4. Borriello, F.
  5. Dobson, R.
  6. Oreja-Guevara, C.
  7. Lin, C.-J.
  8. Zecevic, D.
  9. Craveiro, L.
  10. McElrath, T.
  11. Vukusic, S.
Revue:
Multiple Sclerosis and Related Disorders

ISSN: 2211-0356,  2211-0348

Année de publication: 2022

Volumen: 64

Type: Article

DOI: 10.1016/J.MSARD.2022.103963 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus